Title of article :
Isolation and Characterization of Novel Lytic Phages to Combat Multidrug-Resistant E. coli and Salmonella spp.
Author/Authors :
Nyachieo, Atunga Phage Biology Laboratory - Institute of Primate Research, Karen, Nairobi, Kenya , Alafi, Stephen Department of Biomolecular and Biolaboratory Sciences (BBS) - College of Veterinary Medicine - Animal Resources and Biosecurity (COVAB) - Makerere University, Kampala, Uganda , Jepkurui Mutai, Ivy Phage Biology Laboratory - Institute of Primate Research, Karen, Nairobi, Kenya , Ngolobe, Benson Department of Biomolecular and Biolaboratory Sciences (BBS) - College of Veterinary Medicine - Animal Resources and Biosecurity (COVAB) - Makerere University, Kampala, Uganda , Nabunje, Ritah Department of Biomolecular and Biolaboratory Sciences (BBS) - College of Veterinary Medicine - Animal Resources and Biosecurity (COVAB) - Makerere University, Kampala, Uganda , L. Nakavuma, Jesca Department of Biomolecular and Biolaboratory Sciences (BBS) - College of Veterinary Medicine - Animal Resources and Biosecurity (COVAB) - Makerere University, Kampala, Uganda
Abstract :
Objectives: Escherichia coli and some Salmonella enterica serovars are zoonotic pathogens affecting
livestock and humans. These pathogens cause significant loss of productivity in livestock, severe
morbidity and mortality in humans, and have high antibiotic resistance profiles. Therefore, the
exploitation of lytic phages for therapeutic purposes is important for eliminating these resistant
bacterial strains.
Methods: Thirty-four bacterial stock isolates comprised of 23 E. coli and 11 Salmonella spp. strains
were evaluated for antimicrobial susceptibility to seven antibiotics using the Kirby-Bauer disk diffusion
test. The antibiotics included Ciprofloxacin, Trimethoprim-Sulphamethoxazole, Gentamycin, Imipenem,
Ceftriaxone, Cefotaxime, and Ofloxacin. Twelve (12/23) E. coli and (2/11) Salmonella spp. exhibited
antimicrobial resistance. Selected six (6/12) drug-resistant E. coli strains were subjected to three
different phages (PA5, EHEC005, C11S1A) for efficacy and host range assay. Similarly, two (2/2)
resistant Salmonella strains were exposed to one Salmonella phage A23 for efficacy and host range
assay. The E. coli (C11S1A) phage, which infected most bacterial hosts, was evaluated for optimal
efficiency at various pH and temperatures.
Results: E. coli isolates had the highest resistance 12/23 (52%) compared to Salmonella spp. 2/11(18%)
(p<0.05). Most resistance was against Trimethoprim-Sulphamethoxazole (44%) and (9%) for E. coli and
Salmonella spp., respectively. Furthermore, E. coli (C11S1A) phages killed all the Escherichia coli strains,
while Salmonella phage A23 only lysed the host bacteria. The E. coli (C11S1A) phages were highly
efficacious at 37 0
C and pH 7.4.
Conclusion: The successful isolation of novel lytic E. coli (C11S1A) phages, which killed all the E. coli
strains tested, demonstrates the potential for therapeutic purposes for humans and livestock. J
Microbiol Infect Dis 2021; 11(4):183-190.
Keywords :
Antimicrobial resistance , zoonosis , novel bacteriophage , East Africa
Journal title :
Journal of Medical Microbiology and Infectious Diseases